Guidant Solution To Panel Dilemma Will Not Require New Contak Implants

Guidant's Contak CD "continued access policy" IDE could augment the company's pivotal trial and allow the firm to avoid returning for a second review by the Circulatory System Devices Panel.

More from Archive

More from Medtech Insight